ConductScience.org, home

Paper15280486

Chimeras of duck and heron hepatitis B viruses provide evidence for functional interactions between viral components of pregenomic RNA encapsidation.

Ostrow KM and 1 other. J Virol, 2004. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Chimeras of duck and heron hepatitis B viruses provide evidence for functional interactions between viral components of pregenomic RNA encapsidation. Papers, record 15280486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15280486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chimeras of duck and heron hepatitis B viruses provide evidence for functional interactions between viral components of pregenomic RNA encapsidation.
PubMed
Journal
J Virol
PubMed
Year
2004
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.12
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ostrow KMKristin M
2Loeb DDDaniel D

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AvihepadnavirusMajor topic
CapsidMajor topic
Gene Products, polMajor topic
RNA PrecursorsMajor topic
Recombination, GeneticMajor topic
Viral ProteinsMajor topic
Animals
Cell Line, Tumor
Chickens
Enhancer Elements, Genetic
Hepatitis B Virus, Duck
Virus Assembly

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 CA022443NCI NIH HHSUnited StatesP01CA022443PubMed and NIHNIH RePORTER
P30 CA014520NCI NIH HHSUnited StatesP30CA014520PubMed and NIHNIH RePORTER
P01 CA22443NCI NIH HHSUnited StatesP01CA022443PubMed and NIHNIH RePORTER
P30 CA14520NCI NIH HHSUnited StatesP30CA014520PubMed and NIHNIH RePORTER

Download CSV of grants

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11690862Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.Nature1990https://conductscience.org/library/papers/1690862PubMed
22463489Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting.Nature1989https://conductscience.org/library/papers/2463489PubMed
32214019The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.J Virol1990https://conductscience.org/library/papers/2214019PubMed
42033673cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.J Virol1991https://conductscience.org/library/papers/2033673PubMed
51602535The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly.J Virol1992https://conductscience.org/library/papers/1602535PubMed
61380455Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome.EMBO J1992https://conductscience.org/library/papers/1380455PubMed
77684464An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation.J Virol1993https://conductscience.org/library/papers/7684464PubMed
87504742Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase.J Virol1994https://conductscience.org/library/papers/7504742PubMed
97511168Two regions of an avian hepadnavirus RNA pregenome are required in cis for encapsidation.J Virol1994https://conductscience.org/library/papers/7511168PubMed
107512155Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription.J Virol1994https://conductscience.org/library/papers/7512155PubMed
117520092Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis.J Virol1994https://conductscience.org/library/papers/7520092PubMed
127666546Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo.J Virol1995https://conductscience.org/library/papers/7666546PubMed
138577714Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase.Proc Natl Acad Sci U S A1996https://conductscience.org/library/papers/8577714PubMed
148764010Duck hepatitis B virus polymerase acts as a suppressor of core protein translation.J Virol1996https://conductscience.org/library/papers/8764010PubMed
159009268Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids.EMBO J1997https://conductscience.org/library/papers/9009268PubMed
169499052Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.J Virol1998https://conductscience.org/library/papers/9499052PubMed
179621049Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.J Virol1998https://conductscience.org/library/papers/9621049PubMed
1810516024The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.J Virol1999https://conductscience.org/library/papers/10516024PubMed
1911090144Interaction between hepatitis B virus core protein and reverse transcriptase.J Virol2000https://conductscience.org/library/papers/11090144PubMed
2011773373Small DNA hairpin negatively regulates in situ priming during duck hepatitis B virus reverse transcription.J Virol2002https://conductscience.org/library/papers/11773373PubMed

See all 29 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
29121422Investigating the hepatitis B virus life cycle using engineered reporter hepatitis B viruses.Cancer Sci2018https://conductscience.org/library/papers/29121422PubMed
28769080Few basepairing-independent motifs in the apical half of the avian HBV ε RNA stem-loop determine site-specific initiation of protein-priming.Sci Rep2017https://conductscience.org/library/papers/28769080PubMed
22911745C-terminal substitution of HBV core proteins with those from DHBV reveals that arginine-rich 167RRRSQSPRR175 domain is critical for HBV replication.PLoS One2012https://conductscience.org/library/papers/22911745PubMed
21752921A high level of mutation tolerance in the multifunctional sequence encoding the RNA encapsidation signal of an avian hepatitis B virus and slow evolution rate revealed by in vivo infection.J Virol2011https://conductscience.org/library/papers/21752921PubMed
17206754Hepatitis B virus replication.World J Gastroenterol2007https://conductscience.org/library/papers/17206754PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/15280486

GET https://conductscience.org/api/papers/v1/15280486/references?page=2